×

NanoString Technologies to Present at Upcoming Investor Conferences

SEATTLE, Aug. 21, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science translational research and molecular diagnostic products, today announced that Brad Gray, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences:

  • The 2014 Baird Healthcare Conference in New York on Thursday, September 4, 2014 at 12:50 pm ET.
  • The 2014 Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 10, 2014 at 1:30 pm ET.

Interested parties can access a live audio webcast of these conference presentations from the investor section of the company's website at www.nanostring.com. The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.

About NanoString Technologies, Inc.

NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in over 500 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's technology has now been applied to diagnostic use. The Prosigna Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer.

The NanoString Technologies logo, NanoString, NanoString Technologies, nCounter, and Prosigna are registered trademarks or trademarks of NanoString Technologies, Inc. in various jurisdictions.

For more information, please visit www.nanostring.com.

CONTACT: Investor Contact: Leigh Salvo of Westwicke Partners For NanoString Technologies leigh.salvo@westwicke.com 415-513-1281

Source:NanoString Technologies, Inc.